The Perceived Value of Avoiding Biopsy: Patients' Willingness to Pay for Circulating Tumor DNA T790M Testing

被引：1

作者：

Barnes, T. ^{[1
]}

Laskin, J. ^{[2
]}

Cheema, P. ^{[3
]}

Liu, G. ^{[4
]}

Iqbal, M. ^{[5
]}

Rothenstein, J. ^{[6
]}

Burkes, R. ^{[7
]}

Owen, S. ^{[8
]}

Laurence, D. ^{[1
]}

Carvalhana, I. ^{[3
]}

Markin, L. ^{[2
]}

Wong, L. ^{[2
]}

Perera-Low, N. ^{[1
]}

Sawczak, M. ^{[1
]}

Tsao, M. ^{[9
]}

Leighl, N. ^{[1
]}

机构：

[1] Princess Margaret Canc Ctr, Med Oncol, Toronto, ON, Canada

[2] British Columbia Canc Agcy, Med Oncol, Vancouver, BC, Canada

[3] Sunnybrook Odette Canc Ctr, Med Oncol, Toronto, ON, Canada

[4] Princess Margaret Canc Ctr, Toronto, ON, Canada

[5] Allan Blair Canc Ctr, Med Oncol, Regina, SK, Canada

[6] Lakeridge Hlth Corp, Med Oncol, Oshawa, ON, Canada

[7] Mt Sinai Hosp, Med Oncol, Toronto, ON, Canada

[8] McGill Univ, Med Oncol, Montreal, PQ, Canada

[9] Princess Margaret Canc Ctr, Pathol, Toronto, ON, Canada

来源：

关键词：

EGFR mutation positive lung cancer; T790M detection; Value of novel diagnostics;

D O I：

10.1016/j.jtho.2017.09.1503

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P3.01-062

引用

页码：S2225 / S2225

页数：1